Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences

被引:22
作者
Purcell, C. [1 ]
Cameron, S. [2 ]
Lawton, J. [3 ]
Glasier, A. [4 ]
Harden, J. [3 ]
机构
[1] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, 200 Renfield St, Glasgow G2 3QB, Lanark, Scotland
[2] NHS Lothian, Chalmers Ctr Sexual & Reprod Hlth, Edinburgh, Midlothian, Scotland
[3] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland
[4] Univ Edinburgh, Obstet & Gynaecol, Queens Med Res Inst, Edinburgh, Midlothian, Scotland
关键词
First trimester medical; medication abortion; home self-management; qualitative research; termination of pregnancy; women's experiences; FINAL STAGE; HOME-USE; ABORTION; MISOPROSTOL; MIFEPRISTONE; HEALTH; CARE; CONTRACEPTION; ACCEPTABILITY; SATISFACTION;
D O I
10.1111/1471-0528.14690
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectiveTo explore the experiences of women in Scotland who return home to complete medical termination of pregnancy (TOP) 63days of gestation, after being administered with mifepristone and misoprostol at an NHS TOP clinic. DesignQualitative interview study. SettingOne National Health Service health board (administrative) area in Scotland. Population or SampleWomen in Scotland who had undergone medical TOP 63days, and self-managed passing the pregnancy at home; recruited from three clinics in one NHS health board area between January and July 2014. MethodsIn-depth, semi-structured interviews with 44 women in Scotland who had recently undergone TOP 63days of gestation, and who returned home to pass the pregnancy. Data were analysed thematically using an approach informed by the Framework method. Main outcome measuresWomen's experiences of self-management of TOP 63days of gestation. ResultsKey themes emerging from the analysis related to self-administration of misoprostol in clinic; reasons for choosing home self-management; facilitation of self-management and expectation-setting; experiences of getting home; self-managing and monitoring treatment progress; support for self-management (in person and remotely); and pregnancy self-testing to confirm completion. ConclusionsParticipants primarily found self-administration of misoprostol and home self-management to be acceptable and/or preferable, particularly where this was experienced as a decision made jointly with health professionals. The way in which home self-management is presented to women at clinic requires ongoing attention. Women could benefit from the option of home administration of misoprostol. Tweetable abstractWomen undergoing medical TOP 63days found home self-management to be acceptable and/or preferable. Tweetable abstract Women undergoing medical TOP 63days found home self-management to be acceptable and/or preferable.
引用
收藏
页码:2001 / 2008
页数:8
相关论文
共 31 条
[1]  
Aiken ARA, 2016, BJOG, V124, P1208
[2]  
[Anonymous], HLTH WORK ROL PROV S
[3]   Comparison of unscheduled re-attendance and contraception at discharge, among women having the final stage of early medical abortion at home and those remaining in hospital [J].
Astle, Hannah ;
Cameron, Sharon T. ;
Johnstone, Anne .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2012, 38 (01) :35-40
[4]   Questioning patient satisfaction: An empirical investigation in two outpatient clinics [J].
Avis, M ;
Bond, M ;
Arthur, A .
SOCIAL SCIENCE & MEDICINE, 1997, 44 (01) :85-92
[5]   Women's experiences of the final stage of early medical abortion at home: results of a pilot survey [J].
Cameron, Sharon ;
Glasier, Anna ;
Dewart, Helen ;
Johnstone, Anne .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2010, 36 (04) :213-216
[6]   Comparison of uptake of long-acting reversible contraception after abortion from a hospital or a community sexual and reproductive healthcare setting: an observational study [J].
Cameron, Sharon T. ;
Glasier, Anna ;
Johnstone, Anne .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2017, 43 (01) :31-36
[7]   Shifting abortion care from a hospital to a community sexual and reproductive health care setting [J].
Cameron, Sharon T. ;
Glasier, Anna ;
Johnstone, Anne .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2016, 42 (02) :127-132
[8]   A prospective, non-randomized study of home use of mifepristone for medical abortion in the US [J].
Chong, Erica ;
Frye, Laura J. ;
Castle, Jen ;
Dean, Gillian ;
Kuehl, Laurel ;
Winikoff, Beverly .
CONTRACEPTION, 2015, 92 (03) :215-219
[9]   Having an abortion using mifepristone and home misoprostol: A qualitative analysis of women's experiences [J].
Fielding, SL ;
Edmunds, E ;
Schaff, EA .
PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2002, 34 (01) :34-40
[10]   If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion [J].
Gold, Marji ;
Chong, Erica .
CONTRACEPTION, 2015, 92 (03) :194-196